“…This stimulatory effect of TRH on GH secretion in almost half of our PCO patients is difficult to explain. A paradoxical GH response has been encoun tered in various unrelated conditions, such as acromeg aly [14,15], renal failure [16,17], severe liver disease [18,19], mental illness including schizophrenia [20], depression [21], anorexia nervosa [14], primary acquired hypothyroidism [23] and during normal childhood and adolescence independent of age, sex or height [24,25] or in constitutionally tall children [26]. This nonspecific GH release has been attributed to an aberration of the CNS hypothalamic somatotropic axis which regulates GH secretion, caused either by an alteration of the cellu lar receptors of the somatotroph cells in adenomatous tissue, as postulated in acromegaly [27,28] and/or to disruption of the normal neuroendocrine regulatory mechanisms [14,17,26].…”